Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06610123

Caffeine, CYPA12 and Resistance Training

Influence of CYP1A2 on the Prolonged Effect of Caffeine Intake on Resistance Training

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
48 (estimated)
Sponsor
Alberto Pérez-López · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Introduction: Several studies have evaluated and confirmed the ergogenic effect of acute caffeine intake on sports performance, specifically on strength and power performance. However, it remains to be elucidated how CYP1A2 polymorphism influences the prolonged effects of caffeine on this type of exercise. Objectives: The present study aims to analyze the prolonged effects of caffeine intake on neuromuscular adaptations to resistance training according to CYP1A2 polymorphism in men and women.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCaffeine and Resistance trainingAcute caffeine intake (3 mg/kg) prior each resistance training session of a 8 weeks training program.
DIETARY_SUPPLEMENTPlacebo and Resistance trainingAcute placebo intake (3 mg/kg of maltodextrin) prior each resistance training session of a 8 weeks training program.

Timeline

Start date
2024-04-01
Primary completion
2025-07-30
Completion
2025-07-30
First posted
2024-09-24
Last updated
2024-09-24

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06610123. Inclusion in this directory is not an endorsement.